Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model FirstWord Pharma
Article Source
https://firstwordpharma.com/story/5951809
Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model – FirstWord Pharma